ARCHIVES

Georgetown Sponsors Oncology Agent Development Meeting

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

Bloch Pushes PDQ Promotion To Public, But NCAB Limits It to Physicians

February 17, 1984

Text of Peer Review Of Medenica’s Treatment Of Breast Cancer Patient

April 30, 1993

Institutions Required To Review For Bias under PHS Proposal

July 22, 1994

NIH Funding Strategies, UICC Fellowships

December 4, 1992